APA (7th ed.) Citation

Casadei Gardini, A., Wilmink, H., Bridgewater, J., Macarulla Mercade, T., Sim, H., Verslype, C., . . . Rimassa, L. (2025). 107eP Safety of ivosidenib in patients with mIDH1 CCA: Updated results from the phase IIIb ProvIDHe study. Annals of Oncology, 36, S244. https://doi.org/10.1016/j.annonc.2025.08.540

Chicago Style (17th ed.) Citation

Casadei Gardini, A., et al. "107eP Safety of Ivosidenib in Patients with MIDH1 CCA: Updated Results from the Phase IIIb ProvIDHe Study." Annals of Oncology 36 (2025): S244. https://doi.org/10.1016/j.annonc.2025.08.540.

MLA (9th ed.) Citation

Casadei Gardini, A., et al. "107eP Safety of Ivosidenib in Patients with MIDH1 CCA: Updated Results from the Phase IIIb ProvIDHe Study." Annals of Oncology, vol. 36, 2025, p. S244, https://doi.org/10.1016/j.annonc.2025.08.540.